Riboxin® (Inosine) is a metabolic agent, a precursor of adenosine triphosphate (ATP).
Inosine is an important nucleoside that is essential for proper translation of the genetic code in wobble base pairs. It provides antihypoxic, metabolic and antiarrhythmic effect. It increases the energy balance of the myocardium, improves the coronary blood flow and prevents consequences of intraoperative renal ischemia. The drug participates in the glucose metabolism and promotes metabolism activation under hypoxia and in the absence of ATP.